Terms: = Leukemia AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE
255 results:
1. Bayesian interim analysis for prospective randomized studies: reanalysis of the acute myeloid leukemia HOVON 132 clinical trial.
van der Maas NG; Versluis J; Nasserinejad K; van Rosmalen J; Pabst T; Maertens J; Breems D; Manz M; Cloos J; Ossenkoppele GJ; Floisand Y; Gradowska P; Löwenberg B; Huls G; Postmus D; Pignatti F; Cornelissen JJ
Blood Cancer J; 2024 Mar; 14(1):56. PubMed ID: 38538587
[TBL] [Abstract] [Full Text] [Related]
2. Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial.
Kater AP; Arslan Ö; Demirkan F; Herishanu Y; Ferhanoglu B; Diaz MG; Leber B; Montillo M; Panayiotidis P; Rossi D; Skarbnik A; Tempescul A; Turgut M; Mellink CH; van der Kevie-Kersemaekers AF; Lanham S; Sale B; Del Rio L; Popovic R; Chyla BJ; Busman T; Komlosi V; Wang X; Sail K; Pena GE; Vizkelety T; Forconi F
Lancet Oncol; 2024 Apr; 25(4):463-473. PubMed ID: 38467131
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of clinical profile and role of various prognostic factors in early bone marrow response in children with acute lymphoblastic leukemia treated by Modified Multicenter Protocol (MCP) 841 protocol: Experience from a tertiary care center in North India.
Garg M; Abrol P; Gupta N; Bharti S; Nadda A
Indian J Cancer; 2023 Oct; 60(4):521-527. PubMed ID: 38258870
[TBL] [Abstract] [Full Text] [Related]
4. [Effects of Cytokines on Early Death in Patients with Newly Diagnosed Acute Promyelocytic leukemia].
Zhao SX; Ge YY; Li ZZ; He HP; Shen CM; Shi KQ; Yang TH; DU YY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1315-1321. PubMed ID: 37846678
[TBL] [Abstract] [Full Text] [Related]
5. Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients.
Zhou X; Weng Y; Jiang T; Ou W; Zhang N; Dong Q; Tang X
BMC Cancer; 2023 Oct; 23(1):976. PubMed ID: 37833648
[TBL] [Abstract] [Full Text] [Related]
6. Artificial intelligence and the blood film: Performance of the MC-80 digital morphology analyzer in samples with neoplastic and reactive cell types.
Zini G; Mancini F; Rossi E; Landucci S; d'Onofrio G
Int J Lab Hematol; 2023 Dec; 45(6):881-889. PubMed ID: 37641457
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
[TBL] [Abstract] [Full Text] [Related]
8. Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following leukemia Therapy.
Halton JM; Ma J; Babyn P; Matzinger MA; Kaste SC; Scharke M; Fernandez CV; Miettunen P; Ho J; Alos N; Abish S; Barr R; Cairney E; Dix DB; Grant RM; Israels S; Lewis V; Wilson B; Atkinson S; Cabral D; Cummings E; Rodd C; Stein R; Sbrocchi AM; Jaremko JL; Koujok K; Shenouda N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2023 Aug; 38(8):1104-1115. PubMed ID: 37326443
[TBL] [Abstract] [Full Text] [Related]
9. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial.
Jabbour E; Short NJ; Senapati J; Jain N; Huang X; Daver N; DiNardo CD; Pemmaraju N; Wierda W; Garcia-Manero G; Montalban Bravo G; Sasaki K; Kadia TM; Khoury J; Wang SA; Haddad FG; Jacob J; Garris R; Ravandi F; Kantarjian HM
Lancet Haematol; 2023 Jun; 10(6):e433-e444. PubMed ID: 37187201
[TBL] [Abstract] [Full Text] [Related]
10. The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid leukemia Patients: A Single-Center Retrospective Study.
Liu D; Wang X; Tong J; Zhou L; Chen E; Zhou Z; Xue L; Zhang X; Sun G; Zheng C
Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676738
[No Abstract] [Full Text] [Related]
11. Targeting inflammation in lower-risk MDS.
Gonzalez-Lugo JD; Verma A
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):382-387. PubMed ID: 36485128
[TBL] [Abstract] [Full Text] [Related]
12. Association of systemic inflammatory and autoimmune manifestations with myelodysplastic syndromes: A systematic review and meta-analysis.
Liang Q; Zhao J; Zhang L; Gao Z; Pan H; Fang L; Shi J
Medicine (Baltimore); 2022 Nov; 101(46):e31427. PubMed ID: 36401363
[TBL] [Abstract] [Full Text] [Related]
13. Venetoclax in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid leukemia: A Canadian Cost-Utility Analysis.
Guinan K; Mathurin K; Au Y; Schuh AC; Bui CN; Chai X; Lachaine J
Curr Oncol; 2022 Oct; 29(10):7524-7536. PubMed ID: 36290869
[TBL] [Abstract] [Full Text] [Related]
14. Differential Diagnosis of Hematologic and Solid Tumors Using Targeted Transcriptome and Artificial Intelligence.
Zhang H; Qureshi MA; Wahid M; Charifa A; Ehsan A; Ip A; De Dios I; Ma W; Sharma I; McCloskey J; Donato M; Siegel D; Gutierrez M; Pecora A; Goy A; Albitar M
Am J Pathol; 2023 Jan; 193(1):51-59. PubMed ID: 36243045
[TBL] [Abstract] [Full Text] [Related]
15. The Effect of Aflatoxin B1 on Tumor-Related Genes and Phenotypic Characters of MCF7 and MCF10A Cells.
Adam MAA; Kamal LZM; Kanakal M; Babu D; Dahham SS; Tabana Y; Lok B; Bermoy BM; Yunus MA; Than LTL; Barakat K; Sandai D
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233156
[TBL] [Abstract] [Full Text] [Related]
16. Druggable host gene dependencies in primary effusion lymphoma.
Kuehnle N; Gottwein E
Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
[TBL] [Abstract] [Full Text] [Related]
17. Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute leukemia Working Party (ALWP) of the EBMT.
Nagler A; Ngoya M; Galimard JE; Labopin M; Kröger N; Socié G; Gedde-Dahl T; Potter V; Schroeder T; Platzbecker U; Ganser A; Blaise D; Salmenniemi U; Maertens J; Craddock C; Labussière-Wallet H; Yakoub-Agha I; Savani B; Mohty M
Bone Marrow Transplant; 2022 Dec; 57(12):1788-1796. PubMed ID: 36114249
[TBL] [Abstract] [Full Text] [Related]
18. CircRNA.0007127 triggers apoptosis through the miR-513a-5p/casp8 axis in K-562 cells.
Li X; Zhang Y; Wang N; Yuan Z; Chen X; Chen Q; Deng H; Tong X; Chen H; Duan Y; Wei Y
J Zhejiang Univ Sci B; 2022 Sept 15; 23(9):732-746. PubMed ID: 36111570
[No Abstract] [Full Text] [Related]
19. Association between secondhand smoke and cancers in adults in the US population.
Zhang Z; Li Z; Zhang X; Ye W; Chen J; Wang L; Lin Z; Li J; Li Z
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3447-3455. PubMed ID: 35943599
[TBL] [Abstract] [Full Text] [Related]
20. Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q.
Adema V; Palomo L; Walter W; Mallo M; Hutter S; La Framboise T; Arenillas L; Meggendorfer M; Radivoyevitch T; Xicoy B; Pellagatti A; Haferlach C; Boultwood J; Kern W; Visconte V; Sekeres M; Barnard J; Haferlach T; Solé F; Maciejewski JP
EBioMedicine; 2022 Jun; 80():104059. PubMed ID: 35617825
[TBL] [Abstract] [Full Text] [Related]
[Next]
